Study to Evaluate the Efficacy and Safety of Hyoscine Butylbromide Tablets for the Treatment of Occasional or Recurrent Episodes of Gastric or Intestinal Spasm-like Pain or Discomfort
Clinical trial NCT02242305 · COMPLETED
Trial details
- NCT number
- NCT02242305
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-11-01
- Primary completion
- 2009-07-20
- Enrollment
- 302
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.